Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 14, 2017
Aptose Reports Results for the Third Quarter Ended September 30, 2017
SAN DIEGO and TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
November 14, 2017
Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results
AUSTIN, Texas, Nov. 14, 2017 (GLOBE NEWSWIRE) --  Molecular Templates, Inc. (MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s ...
November 14, 2017
Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer
Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), today announced the appointment of ...
November 14, 2017
Windtree Therapeutics Reports Third Quarter 2017 Financial Results
WARRINGTON, Pa., Nov. 14, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported ...
November 14, 2017
Tel Aviv District Court Ordered MediWound to Purchase Approximately $1.5 Million of PolyHeal Shares; MediWound Weighing an Appeal
YAVNE, Israel, Nov. 13, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe ...
November 14, 2017
Recruitment completed in trial to evaluate the optimal dosing frequency for Zealand's long-acting GLP-2 analog glepaglutide
Copenhagen, Denmark, November 14, 2017 - Zealand Pharma announces that all subjects have been enrolled and dosed in a clinical trial with glepaglutide under an ...
November 14, 2017
UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments
RA’ANANA, Israel and NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
November 14, 2017
VBL Therapeutics Announces Third Quarter 2017 Financial Results
TEL AVIV, Israel, Nov. 14, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
November 14, 2017
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
REDWOOD CITY, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
November 14, 2017
Mateon Provides Corporate Update and Reports Third Quarter 2017 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan ...
November 14, 2017
Albireo Reports Third Quarter 2017 Financial Results
BOSTON, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today reported ...
November 14, 2017
Zogenix to Present at Stifel 2017 Healthcare Conference
EMERYVILLE, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
November 13, 2017
Krystal Biotech Reports that KB103 Received Clearance From RAC Review and Announces Third Quarter 2017 Financial Results
PITTSBURGH, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS), a gene therapy company advancing “off-the-shelf,” topical and intra-dermal treatments for dermatological diseases, today ...
November 13, 2017
Acer Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
November 13, 2017
TRACON Pharmaceuticals Announces Positive Results from Phase 1 Trial of TRC102 and Fludara® in Patients with Advanced Hematologic Malignancy Published in Oncotarget
SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
November 13, 2017
Mirati Therapeutics Announces Advancement Of First-In-Class Opportunities With Sitravatinib And KRAS Inhibitor Programs
SAN DIEGO, Nov. 13, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX) (the Company or Mirati), a clinical-stage targeted oncology company, today announced that it is reprioritizing ...
November 13, 2017
Gemphire Therapeutics Presents Data at American Heart Association (AHA) Scientific Sessions Showing that Gemcabene Significantly Reduces Atherogenic Remnant Lipoprotein and LDL-C as Add-on to Statins in a Cardiometabolic Population and Reports Third Quarter 2017 Financial Results
LIVONIA, Mich., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
November 13, 2017
Kamada Reports Financial Results for Third Quarter and First Nine Months of 2017
REHOVOT, Israel, Nov. 13, 2017 (GLOBE NEWSWIRE) --  Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, today announced financial results ...
November 13, 2017
AC Immune SA Reports Third Quarter 2017 Financial Results and Corporate Update
Lausanne, Switzerland, November 13, 2017 - AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
November 13, 2017
BioTime to Participate in Upcoming Conferences
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that ...
Page 98 of 138